A Full Service Oncology CRO
Celebrating over Thirty Years of Service to Oncology
Theradex® is an international contract research organization providing complete
professional services for the clinical research and development of pharmaceutical
compounds, medical devices and diagnostic tests in the areas of oncology and life-threatening
diseases. Theradex® conducts studies which lead to marketing approval of significant
medical advances; and has built a reputation on assuring the scientific objectivity
and meticulous quality control that fulfills all regulatory requirements. Our expertise
is also available to assist client personnel in expedited development planning and
Over Thirty Year Contract with NCI
For over thirty years, Theradex has held the Clinical Trials Monitoring Service
Contract for the National Cancer Institute in the United States. In that time, we
have not only gained a wealth of experience in the treatment of cancer and allied
diseases, but have also formed long-standing relationships with oncology thought-leaders,
academic and non-academic institutions, regulatory personnel and, most importantly,
our clients. We demonstrate time and time again our flexibility and commitment to
quality, which larger CROs are often unable to attain. On behalf of our clients
and through our global development capability, Theradex® provides a comprehensive
array of services.
Theradex® has provided services for over 1000 oncology protocols for compounds
in all phases of development. Our clients include the US National Cancer Institute
and sponsors ranging from virtual biotech to international pharmaceutical companies.
Our long-standing collaboration with NCI enables Theradex® to gain experience
in new therapeutic approaches as they emerge.
Theradex® does not engage in any agreements that give Theradex® a biased interest
in the outcome of the project. This avoids the creation of a conflict of interest
or bias that might arise if Theradex® were to profit from the development of
our clients' compounds.
The Theradex® philosophy keeps our clients' interests as our primary objective.
All projects are pursued with scientific objectivity, cost economy and time to market
in mind. The Theradex® philosophy emphasizes the importance of developing
effective new drug therapies, and not our financial interest. We are committed
to giving objective opinions on your strategies and protocol design.